{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T10:10:36Z","timestamp":1764238236239,"version":"3.44.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-026"],"award-info":[{"award-number":["2021-I2M-1-026"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ijbiomac.2022.11.225","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T13:51:26Z","timestamp":1669211486000},"page":"1088-1099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Antitumor efficacy of a recombinant EGFR-targeted fusion protein conjugate that induces telomere shortening and telomerase downregulation"],"prefix":"10.1016","volume":"226","author":[{"given":"Hong-yu","family":"Tao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-ming","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-jin","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-su","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.ijbiomac.2022.11.225_bb0005","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1056\/NEJM200004273421710","article-title":"Telomeres, telomerase, and cancer","volume":"342","author":"Buys","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2022.11.225_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.589929","article-title":"TERT-regulation and roles in cancer formation","volume":"11","author":"Dratwa","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.11.225_bb0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13073-016-0324-x","article-title":"Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies","volume":"8","author":"Jafri","year":"2016","journal-title":"Genome Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.11.225_bb0020","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2022.12674","article-title":"Telomerase inhibitors and activators in aging and cancer: a systematic review","volume":"25","author":"Fragkiadaki","year":"2022","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.11.225_bb0025","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s10616-018-0205-9","article-title":"Down regulation of human telomerase reverse transcriptase (hTERT) expression by BIBR1532 in human glioblastoma LN18 cells","volume":"70","author":"Lavanya","year":"2018","journal-title":"Cytotechnology"},{"issue":"13","key":"10.1016\/j.ijbiomac.2022.11.225_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136653","article-title":"Targeting telomere biology in acute lymphoblastic leukemia","volume":"22","author":"Karow","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.11.225_bb0035","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"7","key":"10.1016\/j.ijbiomac.2022.11.225_bb0040","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.ijbiomac.2022.11.225_bb0045","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1002\/cncr.32163","article-title":"Targeted therapy for colorectal cancer metastases: a review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer","volume":"125","author":"Piawah","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.ijbiomac.2022.11.225_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173819","article-title":"Current advancements and future perspectives of immunotherapy in colorectal cancer research","volume":"893","author":"Kishore","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.11.225_bb0055","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s12094-016-1559-0","article-title":"Telomeres and telomerase in the clinical management of colorectal cancer","volume":"19","author":"Pinol-Felis","year":"2017","journal-title":"Clin. Transl. Oncol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.11.225_bb0060","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1349-7006.2010.01796.x","article-title":"EGFR overexpression induces activation of telomerase via PI3K\/AKT-mediated phosphorylation and transcriptional regulation through Hif1-alpha in a cellular model of oral-esophageal carcinogenesis","volume":"102","author":"Heeg","year":"2011","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ijbiomac.2022.11.225_bb0065","article-title":"The small molecule BIBR1532 exerts potential anti-cancer activities in preclinical models of feline oral squamous cell carcinoma through inhibition of telomerase activity and down-regulation of TERT","volume":"7","author":"Altamura","year":"2020","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.ijbiomac.2022.11.225_bb0070","doi-asserted-by":"crossref","first-page":"550","DOI":"10.18632\/genesandcancer.140","article-title":"Telomere length regulation through epidermal growth factor receptor signaling in cancer","volume":"8","author":"Augustine","year":"2017","journal-title":"Genes Cancer"},{"key":"10.1016\/j.ijbiomac.2022.11.225_bb0075","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijbiomac.2021.07.080","article-title":"The development of human serum albumin-based drugs and relevant fusion proteins for cancer therapy","volume":"187","author":"Tao","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.11.225_bb0080","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1634\/theoncologist.2015-0152","article-title":"A phase III study of balugrastim versus pegfilgrastim in breast cancer patients receiving chemotherapy wth doxorubicin and docetaxel","volume":"21","author":"Gladkov","year":"2016","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.11.225_bb0085","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00280-015-2703-1","article-title":"First-in-human, phase I\/IIa dose-escalation and safety study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapy","volume":"75","author":"Avisar","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.11.225_bb0090","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s12032-015-0623-x","article-title":"Phase II dose-finding study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapy","volume":"32","author":"Gladkov","year":"2015","journal-title":"Med. Oncol."},{"issue":"36","key":"10.1016\/j.ijbiomac.2022.11.225_bb0095","doi-asserted-by":"crossref","first-page":"58418","DOI":"10.18632\/oncotarget.11170","article-title":"A recombinantly tailored \u00ce2-defensin that displays intensive macropinocytosis-mediated uptake exerting potent efficacy against K-ras mutant pancreatic cancer","volume":"7","author":"Du","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.ijbiomac.2022.11.225_bb0100","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1021\/acs.bioconjchem.8b00456","article-title":"The recombinant and reconstituted novel albumin-lidamycin conjugate shows lasting tumor imaging and intensively enhanced therapeutic efficacy","volume":"29","author":"Li","year":"2018","journal-title":"Bioconjug. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.11.225_bb0105","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1021\/acs.molpharmaceut.8b00234","article-title":"A macropinocytosis-intensifying albumin domain-based scFv antibody and its conjugate directed against K-ras mutant pancreatic cancer","volume":"15","author":"Wang","year":"2018","journal-title":"Mol. Pharm."},{"issue":"11","key":"10.1016\/j.ijbiomac.2022.11.225_bb0110","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.7164\/antibiotics.41.1575","article-title":"A new macromolecular antitumor antibiotic, C-1027. I. Discovery, taxonomy of producing organism, fermentation and biological activity","volume":"41","author":"Hu","year":"1988","journal-title":"J. Antibiot."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.11.225_bb0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/187152008783497055","article-title":"Enediyne anticancer antibiotic lidamycin: chemistry, biology and pharmacology","volume":"8","author":"Shao","year":"2008","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"17","key":"10.1016\/j.ijbiomac.2022.11.225_bb0120","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.7314\/APJCP.2014.15.17.7043","article-title":"Hsp90 inhibitor geldanamycin enhances the antitumor efficacy of enediyne lidamycin in association with reduced DNA damage repair","volume":"15","author":"Han","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.11.225_bb0125","first-page":"597","article-title":"Lidamycin induces marked G2 cell cycle arrest in human colon carcinoma HT-29 cells through activation of p38 MAPK pathway","volume":"17","author":"Liu","year":"2007","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.11.225_bb0130","first-page":"475","article-title":"Induction of apoptosis and erythroid differentiation of human chronic myelogenous leukemia K562 cells by low concentrations of lidamycin","volume":"41","author":"Zhang","year":"2019","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.11.225_bb0135","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4161\/cbt.27626","article-title":"Synergistic inhibition of angiogenesis and glioma cell-induced angiogenesis by the combination of temozolomide and enediyne antibiotic lidamycin","volume":"15","author":"Li","year":"2014","journal-title":"Cancer Biol. Ther."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.11.225_bb0140","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/1878-0261.12166","article-title":"A novel enediyne-integrated antibody-drug conjugate shows promising antitumor efficacy against CD30(+) lymphomas","volume":"12","author":"Wang","year":"2018","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.11.225_bb0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/1061186X.2015.1055568","article-title":"A novel antibody-drug conjugate anti-CD19(Fab)-LDM in the treatment of B-cell non-hodgkin lymphoma xenografts with enhanced anticancer activity","volume":"24","author":"Jiang","year":"2016","journal-title":"J. Drug Target."},{"issue":"7451","key":"10.1016\/j.ijbiomac.2022.11.225_bb0150","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nature12138","article-title":"Macropinocytosis of protein is an amino acid supply route in ras-transformed cells","volume":"497","author":"Commisso","year":"2013","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.11.225_bb0155","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/1878-0261.12698","article-title":"RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K-RAS mutant tumors","volume":"14","author":"Yuan","year":"2020","journal-title":"Mol. Oncol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.11.225_bb0160","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S1470-2045(14)70236-0","article-title":"Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial","volume":"15","author":"Middleton","year":"2014","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.11.225_bb0165","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12967-021-02905-3","article-title":"NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma","volume":"19","author":"Haakensen","year":"2021","journal-title":"J. Transl. Med."},{"issue":"11","key":"10.1016\/j.ijbiomac.2022.11.225_bb0170","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1038\/leu.2017.78","article-title":"Imetelstat, a telomerase inhibitor, differentially affects normal and malignant megakaryopoiesis","volume":"31","author":"Mosoyan","year":"2017","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.ijbiomac.2022.11.225_bb0175","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.bcp.2011.07.093","article-title":"Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications","volume":"82","author":"Singh","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.11.225_bb0180","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1158\/2159-8290.CD-14-0609","article-title":"Induction of telomere dysfunction mediated by the telomerase substrate precursor 6-thio-2'-deoxyguanosine","volume":"5","author":"Mender","year":"2015","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.11.225_bb0185","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/annonc\/mdu550","article-title":"A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer","volume":"26","author":"Chiappori","year":"2015","journal-title":"Ann. Oncol."},{"issue":"22","key":"10.1016\/j.ijbiomac.2022.11.225_bb0190","doi-asserted-by":"crossref","first-page":"31639","DOI":"10.18632\/oncotarget.9335","article-title":"Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner","volume":"7","author":"Frink","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.11.225_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020482","article-title":"Telomere length dynamics and the evolution of cancer genome architecture","volume":"19","author":"Cleal","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.11.225_bb0200","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrg2763","article-title":"Alternative lengthening of telomeres: models, mechanisms and implications","volume":"11","author":"Cesare","year":"2010","journal-title":"Nat. Rev. Genet."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.11.225_bb0205","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ccell.2020.05.020","article-title":"Telomere stress potentiates STING-dependent anti-tumor immunity","volume":"38","author":"Mender","year":"2020","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.11.225_bb0210","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1158\/1535-7163.MCT-11-0820","article-title":"Antitumor activity of a novel bispecific antibody that targets the ErbB2\/ErbB3 oncogenic unit and inhibits heregulin-induced activation of ErbB3","volume":"11","author":"McDonagh","year":"2012","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.11.225_bb0215","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00262-004-0624-7","article-title":"Pharmacokinetics and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice","volume":"54","author":"Melder","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ijbiomac.2022.11.225_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105551","article-title":"Albumin fusion at the N-terminus or C-terminus of human lactoferrin leads to improved pharmacokinetics and anti-proliferative effects on cancer cell lines","volume":"155","author":"Ueda","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2022.11.225_bb0225","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00262-010-0862-9","article-title":"Bioactivity and pharmacokinetics of two human serum albumin-thymosin alpha1-fusion proteins, rHSA-Talpha1 and rHSA-L-Talpha1, expressed in recombinant Pichia pastoris","volume":"59","author":"Chen","year":"2010","journal-title":"Cancer Immunol. Immunother."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813022027842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813022027842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:58:09Z","timestamp":1758880689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813022027842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":45,"alternative-id":["S0141813022027842"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.11.225","relation":{},"ISSN":["0141-8130"],"issn-type":[{"type":"print","value":"0141-8130"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antitumor efficacy of a recombinant EGFR-targeted fusion protein conjugate that induces telomere shortening and telomerase downregulation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.11.225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}